Pituitary apoplexy of a gonadotroph adenoma following gonadotrophin releasing hormone agonist therapy for prostatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pituitary apoplexy of a gonadotroph adenoma following gonadotrophin releasing hormone agonist therapy for prostatic cancer

Published:1997-10 Issue:9 Volume:20 Page:566-568
ISSN:0391-4097
Container-title:Journal of Endocrinological Investigation
language:en
Short-container-title:J Endocrinol Invest

Author:

Reznik Y.,Chapon F.,Lahlou N.,Deboucher N.,Mahoudeau J.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/BF03348020.pdf

Reference13 articles.

1. Kuhn J.M., Billebaud T., Navratil H., Moulonguet A., Fiet J., Grise P., Louis J.F., Costa P., Husson J.M., Dahan R., Bertagna C., Edelstein R. Prevention of the transient adverse effects of a gonadotrophin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide). N. Engl. J. Med. 321: 413, 1989.

2. Kwekkeboom D.J., de Jong F.H., Lamberts S.W.J. Gonadotrophin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotrophin-releasing hormone, and bromocriptine. J. Clin. Endocrinol. Metab. 68: 1128, 1989.

3. Daneshdoost L., Gennarelli T.A., Bashey H.M., Savino P.J., Sergott R.C., Bosley T.M., Snyder P.J. Recognition of gonadotroph adenomas in women. N. Engl. J. Med. 324: 589, 1991.

4. Sassolas G., Lejeune H., Trouillas J., Forest M.G., Claustrat B., Lahlou N., Loras B. Gonadotrophin-releasing hormone agonists are unsuccessful in reducing tumoural gonadotrophin secretion in two patients with gonadotrophin-secreting pituitary adenomas. J. Clin. Endocrinol. Metab. 67: 180, 1988.

5. Klibanski A., Jameson J.L., Biller B.M.K., Crowley W.F., Zervas N.T., Rivier J., Vale W.W., Bikkal H. Gonadotrophin and alpha-subunit responses to chronic gonadotrophin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumours. J. Clin. Endocrinol. Metab. 68: 81, 1989.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review;Journal of Cancer Research and Clinical Oncology;2021-06-22

2. GnRH agonist-associated pituitary apoplexy: a case series and review of the literature;Pituitary;2021-04-09

3. Drug-Induced Pituitary Disorders;Drug-induced Neurological Disorders;2021

4. Pituitary apoplexy induced by gonadotropin-releasing hormone agonist administration: a rare complication of prostate cancer treatment;Endocrinology, Diabetes & Metabolism Case Reports;2020-06-04

5. Pituitary apoplexy: a rare complication of leuprolide therapy in prostate cancer treatment;BMJ Case Reports;2017-07-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3